Fraport Crecimiento futuro
Future controles de criterios 1/6
Fraport se prevé un crecimiento anual de los beneficios y los ingresos de 11.2% y 3.9% respectivamente. Se prevé que el BPA sea de grow en 10.9% al año. Se prevé que la rentabilidad de los fondos propios sea de 10.4% en 3 años.
Información clave
5.6%
Tasa de crecimiento de los beneficios
7.3%
Tasa de crecimiento del BPA
Crecimiento de los beneficios de Infrastructure | 5.6% |
Tasa de crecimiento de los ingresos | 2.8% |
Rentabilidad financiera futura | 9.5% |
Cobertura de analistas | Good |
Última actualización | 05 Apr 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Estimating The Intrinsic Value Of Fraport AG (ETR:FRA)
Apr 06Results: Fraport AG Beat Earnings Expectations And Analysts Now Have New Forecasts
Mar 22Market Still Lacking Some Conviction On Fraport AG (ETR:FRA)
Mar 11Should You Be Adding Fraport (ETR:FRA) To Your Watchlist Today?
Feb 07Here's Why Fraport (ETR:FRA) Is Weighed Down By Its Debt Load
Jan 23When Should You Buy Fraport AG (ETR:FRA)?
Jan 08Fraport (ETR:FRA) Could Be Struggling To Allocate Capital
Dec 26Fraport AG's (ETR:FRA) Intrinsic Value Is Potentially 96% Above Its Share Price
Oct 19At €48.92, Is It Time To Put Fraport AG (ETR:FRA) On Your Watch List?
Oct 03Fraport (ETR:FRA) Is Reinvesting At Lower Rates Of Return
Sep 17Fraport (ETR:FRA) Seems To Be Using A Lot Of Debt
Sep 02An Intrinsic Calculation For Fraport AG (ETR:FRA) Suggests It's 47% Undervalued
Jul 19Should You Think About Buying Fraport AG (ETR:FRA) Now?
Jun 23Returns On Capital At Fraport (ETR:FRA) Paint A Concerning Picture
Jun 09Is Fraport (ETR:FRA) A Risky Investment?
May 26An Intrinsic Calculation For Fraport AG (ETR:FRA) Suggests It's 39% Undervalued
Apr 14Is There Now An Opportunity In Fraport AG (ETR:FRA)?
Mar 18Returns On Capital Signal Tricky Times Ahead For Fraport (ETR:FRA)
Mar 01Fraport (ETR:FRA) Has A Somewhat Strained Balance Sheet
Feb 08Why Fraport AG (ETR:FRA) Could Be Worth Watching
Dec 16Fraport (ETR:FRA) May Have Issues Allocating Its Capital
Nov 28Does Fraport (ETR:FRA) Have A Healthy Balance Sheet?
Oct 28Fraport (ETR:FRA) Will Want To Turn Around Its Return Trends
Aug 26Is Fraport (ETR:FRA) A Risky Investment?
Jul 15Fraport (ETR:FRA) Might Be Having Difficulty Using Its Capital Effectively
May 13What Is Fraport AG's (ETR:FRA) Share Price Doing?
Mar 22Fraport (ETR:FRA) Has Debt But No Earnings; Should You Worry?
Feb 23There Are Reasons To Feel Uneasy About Fraport's (ETR:FRA) Returns On Capital
Nov 10Here's Why Shareholders Should Examine Fraport AG's (ETR:FRA) CEO Compensation Package More Closely
May 25Is Fraport (ETR:FRA) Using Debt In A Risky Way?
Apr 07A Look At The Intrinsic Value Of Fraport AG (ETR:FRA)
Mar 02If You Had Bought Fraport's (ETR:FRA) Shares Three Years Ago You Would Be Down 47%
Feb 12Could The Fraport AG (ETR:FRA) Ownership Structure Tell Us Something Useful?
Jan 17Health Check: How Prudently Does Fraport (ETR:FRA) Use Debt?
Dec 21Does Fraport's (ETR:FRA) CEO Salary Compare Well With The Performance Of The Company?
Nov 29Previsiones de crecimiento de beneficios e ingresos
Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
---|---|---|---|---|---|
12/31/2026 | 4,344 | 484 | 426 | 1,077 | 9 |
12/31/2025 | 4,262 | 481 | 63 | 1,011 | 14 |
12/31/2024 | 4,193 | 446 | -527 | 918 | 12 |
12/31/2023 | 4,051 | 393 | -667 | 863 | N/A |
9/30/2023 | 3,900 | 383 | -468 | 891 | N/A |
6/30/2023 | 3,698 | 262 | -400 | 896 | N/A |
3/31/2023 | 3,465 | 219 | -362 | 868 | N/A |
12/31/2022 | 3,234 | 132 | -366 | 787 | N/A |
9/30/2022 | 3,049 | 52 | -357 | 802 | N/A |
6/30/2022 | 2,720 | 14 | -360 | 773 | N/A |
3/31/2022 | 2,336 | 40 | -514 | 610 | N/A |
12/31/2021 | 2,181 | 83 | -761 | 393 | N/A |
9/30/2021 | 1,899 | -45 | -1,021 | 108 | N/A |
6/30/2021 | 1,616 | -426 | -1,484 | -334 | N/A |
3/31/2021 | 1,439 | -693 | -1,675 | -543 | N/A |
12/31/2020 | 1,715 | -658 | -1,354 | -236 | N/A |
9/30/2020 | 2,209 | -474 | -1,152 | 35 | N/A |
6/30/2020 | 2,872 | 52 | -700 | 488 | N/A |
3/31/2020 | 3,602 | 361 | -319 | 915 | N/A |
12/31/2019 | 3,744 | 421 | -421 | 952 | N/A |
9/30/2019 | 3,822 | 508 | -316 | 943 | N/A |
6/30/2019 | 3,767 | 497 | -331 | 845 | N/A |
3/31/2019 | 3,637 | 481 | -232 | 851 | N/A |
12/31/2018 | 3,514 | 474 | -26 | 802 | N/A |
9/30/2018 | 3,288 | 366 | 75 | 759 | N/A |
6/30/2018 | 3,146 | 337 | -83 | 738 | N/A |
3/31/2018 | 3,061 | 335 | -1,208 | 773 | N/A |
12/31/2017 | 2,971 | 330 | -1,084 | 819 | N/A |
9/30/2017 | 2,894 | 468 | N/A | 794 | N/A |
6/30/2017 | 2,755 | 411 | N/A | 732 | N/A |
3/31/2017 | 2,643 | 380 | N/A | 619 | N/A |
12/31/2016 | 2,621 | 375 | N/A | 583 | N/A |
9/30/2016 | 2,624 | 250 | N/A | 628 | N/A |
6/30/2016 | 2,612 | 271 | N/A | 633 | N/A |
3/31/2016 | 2,625 | 280 | N/A | 629 | N/A |
12/31/2015 | 2,629 | 277 | N/A | 652 | N/A |
9/30/2015 | 2,595 | 274 | N/A | 622 | N/A |
6/30/2015 | 2,543 | 244 | N/A | 577 | N/A |
3/31/2015 | 2,480 | 238 | N/A | 546 | N/A |
12/31/2014 | 2,423 | 235 | N/A | 506 | N/A |
9/30/2014 | 2,400 | 223 | N/A | 492 | N/A |
6/30/2014 | 2,388 | 230 | N/A | 454 | N/A |
3/31/2014 | 2,396 | 222 | N/A | 436 | N/A |
12/31/2013 | 2,408 | 221 | N/A | 454 | N/A |
9/30/2013 | 2,424 | 211 | N/A | 296 | N/A |
6/30/2013 | 2,469 | 238 | N/A | 559 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: FRA(11.2% al año) es superior a la tasa de ahorro (0.6%).
Beneficios frente mercado: FRASe prevé que los beneficios de la empresa (11.2% al año) crezcan menos que el mercado German (13% al año).
Beneficios de alto crecimiento: FRASe prevé que los beneficios de la empresa crezcan, pero no significativamente.
Ingresos vs. Mercado: FRA(3.9% al año) se prevé que crezca más despacio que el mercado de German (4.8% al año).
Ingresos de alto crecimiento: FRASe prevé que los ingresos de la empresa (3.9% al año) crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: FRASe prevé que la Rentabilidad de los fondos propios de la empresa sea baja dentro de 3 años (10.2%).